Combination of physical activity, nutrition, or other metabolic factors and vaccine response

Kenneth W. Hance, Connie J. Rogers, Stephen D. Hursting, John W. Greiner

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

A number of lifestyle factors that reduce cancer risk in the primary prevention setting may be potential new targets for use in combination with cancer vaccines. This review discusses the modulation of energy balance (physical activity, calorie restriction, and obesity prevention), and the supplementation with natural and synthetic analogs of vitamins A and E, as potential interventions for use in combination with cancer vaccines. Additionally, the pharmacologic manipulation of nutrient metabolism in the tumor microenvironment (e. g., arachidonic acid, arginine, tryptophan, and glucose metabolism) is discussed. This review includes a brief overview of the role of each agent in primary cancer prevention; outlines the effects of these agents on immune function, specifically adaptive and/or anti-tumor immune mechanisms, when known; and discusses the potential use of these interventions in combination with therapeutic cancer vaccines. Modulation of energy balance through exercise and strategies targeting nutrient metabolism in the tumor microenvironment represent the most promising interventions to partner with therapeutic cancer vaccines. Additionally, the use of vitamin E succinate and the retinoid X receptordirected rexinoids in combination with cancer vaccines offer promise. In summary, a number of energy balance-and nutrition-related interventions are viable candidates for further study in combination with cancer vaccines.

Original languageEnglish (US)
Pages (from-to)4997-5029
Number of pages33
JournalFrontiers in Bioscience
Volume12
Issue number13
DOIs
StatePublished - Sep 1 2007

Fingerprint

Cancer Vaccines
Nutrition
Vaccines
Energy balance
Metabolism
Tumors
Tumor Microenvironment
Primary Prevention
Vitamin E
Nutrients
Modulation
Food
Neoplasms
Retinoids
Succinic Acid
Vitamin A
Arachidonic Acid
Tryptophan
Arginine
Life Style

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Hance, Kenneth W. ; Rogers, Connie J. ; Hursting, Stephen D. ; Greiner, John W. / Combination of physical activity, nutrition, or other metabolic factors and vaccine response. In: Frontiers in Bioscience. 2007 ; Vol. 12, No. 13. pp. 4997-5029.
@article{819a98a0b6994801b0cf47bffcfb3264,
title = "Combination of physical activity, nutrition, or other metabolic factors and vaccine response",
abstract = "A number of lifestyle factors that reduce cancer risk in the primary prevention setting may be potential new targets for use in combination with cancer vaccines. This review discusses the modulation of energy balance (physical activity, calorie restriction, and obesity prevention), and the supplementation with natural and synthetic analogs of vitamins A and E, as potential interventions for use in combination with cancer vaccines. Additionally, the pharmacologic manipulation of nutrient metabolism in the tumor microenvironment (e. g., arachidonic acid, arginine, tryptophan, and glucose metabolism) is discussed. This review includes a brief overview of the role of each agent in primary cancer prevention; outlines the effects of these agents on immune function, specifically adaptive and/or anti-tumor immune mechanisms, when known; and discusses the potential use of these interventions in combination with therapeutic cancer vaccines. Modulation of energy balance through exercise and strategies targeting nutrient metabolism in the tumor microenvironment represent the most promising interventions to partner with therapeutic cancer vaccines. Additionally, the use of vitamin E succinate and the retinoid X receptordirected rexinoids in combination with cancer vaccines offer promise. In summary, a number of energy balance-and nutrition-related interventions are viable candidates for further study in combination with cancer vaccines.",
author = "Hance, {Kenneth W.} and Rogers, {Connie J.} and Hursting, {Stephen D.} and Greiner, {John W.}",
year = "2007",
month = "9",
day = "1",
doi = "10.2741/2444",
language = "English (US)",
volume = "12",
pages = "4997--5029",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "13",

}

Combination of physical activity, nutrition, or other metabolic factors and vaccine response. / Hance, Kenneth W.; Rogers, Connie J.; Hursting, Stephen D.; Greiner, John W.

In: Frontiers in Bioscience, Vol. 12, No. 13, 01.09.2007, p. 4997-5029.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Combination of physical activity, nutrition, or other metabolic factors and vaccine response

AU - Hance, Kenneth W.

AU - Rogers, Connie J.

AU - Hursting, Stephen D.

AU - Greiner, John W.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - A number of lifestyle factors that reduce cancer risk in the primary prevention setting may be potential new targets for use in combination with cancer vaccines. This review discusses the modulation of energy balance (physical activity, calorie restriction, and obesity prevention), and the supplementation with natural and synthetic analogs of vitamins A and E, as potential interventions for use in combination with cancer vaccines. Additionally, the pharmacologic manipulation of nutrient metabolism in the tumor microenvironment (e. g., arachidonic acid, arginine, tryptophan, and glucose metabolism) is discussed. This review includes a brief overview of the role of each agent in primary cancer prevention; outlines the effects of these agents on immune function, specifically adaptive and/or anti-tumor immune mechanisms, when known; and discusses the potential use of these interventions in combination with therapeutic cancer vaccines. Modulation of energy balance through exercise and strategies targeting nutrient metabolism in the tumor microenvironment represent the most promising interventions to partner with therapeutic cancer vaccines. Additionally, the use of vitamin E succinate and the retinoid X receptordirected rexinoids in combination with cancer vaccines offer promise. In summary, a number of energy balance-and nutrition-related interventions are viable candidates for further study in combination with cancer vaccines.

AB - A number of lifestyle factors that reduce cancer risk in the primary prevention setting may be potential new targets for use in combination with cancer vaccines. This review discusses the modulation of energy balance (physical activity, calorie restriction, and obesity prevention), and the supplementation with natural and synthetic analogs of vitamins A and E, as potential interventions for use in combination with cancer vaccines. Additionally, the pharmacologic manipulation of nutrient metabolism in the tumor microenvironment (e. g., arachidonic acid, arginine, tryptophan, and glucose metabolism) is discussed. This review includes a brief overview of the role of each agent in primary cancer prevention; outlines the effects of these agents on immune function, specifically adaptive and/or anti-tumor immune mechanisms, when known; and discusses the potential use of these interventions in combination with therapeutic cancer vaccines. Modulation of energy balance through exercise and strategies targeting nutrient metabolism in the tumor microenvironment represent the most promising interventions to partner with therapeutic cancer vaccines. Additionally, the use of vitamin E succinate and the retinoid X receptordirected rexinoids in combination with cancer vaccines offer promise. In summary, a number of energy balance-and nutrition-related interventions are viable candidates for further study in combination with cancer vaccines.

UR - http://www.scopus.com/inward/record.url?scp=34547678241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547678241&partnerID=8YFLogxK

U2 - 10.2741/2444

DO - 10.2741/2444

M3 - Review article

C2 - 17569626

AN - SCOPUS:34547678241

VL - 12

SP - 4997

EP - 5029

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 13

ER -